Stockscreener 앱 받기
92.00
6.24%
5.40
시간 외 거래:
91.99
-0.01
-0.01%
Celcuity Inc 주식(CELC)의 최신 뉴스
Is Celcuity (CELC) A Bargain As Losses Widen Ahead Of Its First Launch? - Yahoo Finance
How Investors May Respond To Celcuity (CELC) Winning FDA Nod For Revtopik Amid Wider Quarterly Loss - Yahoo Finance
The Bull Case For Celcuity (CELC) Could Change Following Revtopik’s FDA Approval And NCCN Category 1 Status - simplywall.st
Celcuity (NASDAQ:CELC) Stock Rating Lowered by Wall Street Zen - MarketBeat
CELC Stock Records Worst Day Ever After Late-Stage Breast Cancer Trial Results — What’s Driving The Selloff? - Stocktwits
Needham cuts Celcuity stock price target on updated revenue model By Investing.com - Investing.com Australia
Celcuity Stock Price Forecast. Should You Buy CELC? - StockInvest.us
Celcuity (NASDAQ:CELC) Releases Quarterly Earnings Results, Misses Estimates By $0.28 EPS - MarketBeat
H.C. Wainwright Maintains Celcuity(CELC.US) With Buy Rating, Maintains Target Price $155 - Moomoo
Celcuity (CELC) Q2 2026 Ergebniskonferenz: REVTORPYK-Markteinführung für Ende Q3 geplant - TradingKey
Celcuity's (CELC) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Celcuity (NASDAQ:CELC) Shares Gap Down on Disappointing Earnings - MarketBeat
Celcuity remains a Buy as FDA approval and stro... - Pluang
Stifel cuts Celcuity stock price target on refined market model - Investing.com
Stifel cuts Celcuity stock price target on refined market model By Investing.com - Investing.com Australia
Celcuity (NASDAQ:CELC) Given New $140.00 Price Target at Needham & Company LLC - MarketBeat
Celcuity: REVTORPYK Is Now A Commercial Story (NASDAQ:CELC) - Seeking Alpha
Celcuity (NASDAQ:CELC) Given New $150.00 Price Target at Stifel Nicolaus - MarketBeat
Celcuity Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Celcuity Analysts Slash Their Forecasts After Q2 Loss - Benzinga
Celcuity Inc. Stock 12‑Month Price Target Cut to $160.64, Implies 85% Upside - TradingView
Needham cuts Celcuity stock price target on updated revenue model - Investing.com
Celcuity Inc. Stock 12‑Month Price Target Cut to $162.18, Implies 87% Upside - TradingView
Celcuity Q2 Net Loss Widens to $73.6M as R&D Spending Rises - minichart.com.sg
CELC SWOT Analysis: Key Insights from 10-Q Filing - GuruFocus
CELCUITY INC. : JEFFERIES RAISES TARGET PRICE TO $163 FROM $153 - moomoo.com
Celcuity Q2 Adjusted Loss Widens - moomoo.com
Celcuity Q2 2026 Earnings Call Transcript - MarketBeat
CELC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Celcuity Inc. - ACCESS Newswire
CELCUITY INC. : NEEDHAM CUTS TARGET PRICE TO $140 FROM $157 - Bitget
Celcuity Q2 Earnings Call Highlights - MarketBeat
CELCUITY ($CELC) Releases Q2 2026 Earnings - Quiver Quantitative
CELC: FDA approval, strong trial data, and robust cash position set stage for late Q3 launch - TradingView
Celcuity Inc. (CELC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Celcuity Reports Q2 2026 Form 10-Q Highlighting FDA-Approved REVTORPYK and Ongoing Clinical Trials - Kalkine Media
Celcuity Q2 Results: Net Loss Widens To $78.9 Million Amid Launch Prep - scanx.trade
Celcuity Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Celcuity Inc. (NASDAQ: CELC) deepens loss as it raises $575M in converts - Stock Titan
Celcuity Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Celcuity beats second quarter loss estimates By Investing.com - Investing.com South Africa
Celcuity beats second quarter loss estimates - Investing.com
Celcuity posts narrower-than-expected loss as R&D costs decreased - TradingView
Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Earnings Flash (CELC) Celcuity Inc. Posts Q2 Adjusted Loss $1.07 per Share, vs. FactSet Est of $-1.12 - marketscreener.com
Celcuity Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Celcuity earnings loom as breast cancer drug approval fuels optimism By Investing.com - Investing.com Canada
Celcuity, Inc. (NASDAQ:CELC) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
CELC Stock Jumps After Hours On Positive Breast Cancer Trial Data - Stocktwits
California State Teachers Retirement System Acquires 12,201 Shares of Celcuity, Inc. $CELC - MarketBeat
Bank of America Corp DE Sells 262,789 Shares of Celcuity, Inc. $CELC - MarketBeat
Assenagon Asset Management S.A. Buys New Shares in Celcuity, Inc. $CELC - MarketBeat
Understanding the Setup: (CELC) and Scalable Risk - Stock Traders Daily
Hennion & Walsh Asset Management Inc. Cuts Stake in Celcuity, Inc. $CELC - MarketBeat
Celcuity (CELC.US) will release its earnings report after market close on August 13. - Moomoo
Celcuity Inc (CELC) Stock News Today - tradingkey.com
Celcuity faces investigation after FDA approval delays cause stock to drop 17.6%. - Pluang
Celcuity Inc. (CELC) stock price, news, quote and history - Yahoo Finance Australia
Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call - GlobeNewswire
Celcuity (CELC) Expected to Announce Earnings on Thursday - marketbeat.com
Celcuity Inc. (NASDAQ:CELC): When Will It Breakeven? - moomoo.com
Law firm probes Celcuity over delayed breast ca... - pluang.com
CELC SHAREHOLDER ALERT: Celcuity Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - lincolnjournal.com
CELC Investors Have Opportunity to Join Celcuity Inc. Fraud Investigation with SBS Law - TradingView
0.52%
0.07%
자본화:
|
볼륨(24시간):